Showing results (51-60 of 117) with videos related to
Sort By:
Pageof 12
Clinical Nutrition (Edinburgh, Scotland)|October 25, 2016
Effects of acute dietary weight loss on postprandial plasma bile acid responses in obese insulin resistant subjectsF Samuel van Nierop, W Kulik, Erik Endert, et al.Expert Opinion on Drug Metabolism & Toxicology|May 25, 2016
A short-term high fat diet increases exposure to midazolam and omeprazole in healthy subjectsRoos Achterbergh, Laureen A Lammers, Samuel van Nierop, et al.Metabolism: Clinical and Experimental|April 18, 2016
Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humansKasper W Ter Horst, Pim W Gilijamse, Mariette T Ackermans, et al.American Journal of Physiology. Endocrinology and Metabolism|June 4, 2015
Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolismMarieke G Schooneman, Gabriella A M Ten Have, Naomi van Vlies, et al.Journal of Medical Virology|February 24, 2000
Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasiaD J Marais, R C Rose, C Lane, et al.Clinical Science (London, England : 1979)|October 24, 2008
Muscle acylcarnitines during short-term fasting in lean healthy menMaarten R Soeters, Hans P Sauerwein, Marinus Duran, et al.Frontiers in Physiology|June 29, 2018
<i>In Silico</i> Analysis Identifies Intestinal Transit as a Key Determinant of Systemic Bile Acid MetabolismFianne L P Sips, Hannah M Eggink, Peter A J Hilbers, et al.The Lancet. Diabetes & Endocrinology|September 19, 2016
Clinical relevance of the bile acid receptor TGR5 in metabolismF Samuel van Nierop, Matthijs J Scheltema, Hannah M Eggink, et al.Journal of Eating Disorders|May 19, 2025
Lymphocyte subsets and the increased risk for opportunistic infections in severe restrictive anorexia nervosaPetra Vidmar, Josje Altenburg, Ester M van Leeuwen, et al.Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot StudySuzanne Meiring, Annieke C G van Baar, Nikolaj Sørensen, et al.Pageof 12